Functional Importance of the Noradrenaline System in connection with Memory Impairments and Alzheimer's Disease

Background and aims

Noradrenaline is a neurotransmitter. The brain synthesizes all of its noradrenaline in the locus coeruleus, a small nucleus in the brainstem. It is known that this nucleus is affected early on in the onset of Alzheimer's disease. Little is known, however, about how this relationship affects the symptoms and the course of the disease.

Findings obtained from study of this relationship could conceivably lead to treatment strategies that specifically target the noradrenaline system.

Course of the study

Study participants with mild Alzheimer's dementia, and patients with slight memory impairments, will be examined via magnetic resonance imaging (MRI), electroencephalography (EEG) and measurement of pupil width.

A full set of information about the study can be downloaded here (in German only): Flyer

Principle Investigator: PD Dr. Klaus Fließbach
Start of the study: 2013
Status: mono centric (DZNE Bonn), ongoing, recruiting active

Study Coordination / Project Management

Priv.-Doz. Dr. Dipl.-Psych. Klaus Fließbach
 klaus.fliessbach@ukb.uni-bonn.de
 +49 228 287-15717
 +49 228 287-19419

M. Sc. Verena Kiven
 verena.kiven@dzne.de
 +49 228 43302-873
 +49 228 43302-812

Info-Hotline

Thursdays 1:30-4:30 pm

Patients +49 800-7799001

(free of charge)

Professionals +49 180-779900

(9 Cent/Min. German landline, mobile and out of Germany possibly more expensive)

Inform yourself on our website cookie-free. However, we would be pleased if you would allow us to use statistical cookies. Your browser settings regarding cookies are currently as follows:
More information can be found in our Privacy policy.